Recurrent events in meta-analysis of multiple clinical trials.

Y Wang, M Flather, S Yusuf, Y H Wang, L X Li, Z C Wang
{"title":"Recurrent events in meta-analysis of multiple clinical trials.","authors":"Y Wang,&nbsp;M Flather,&nbsp;S Yusuf,&nbsp;Y H Wang,&nbsp;L X Li,&nbsp;Z C Wang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To study the efficacy and safety of drug or therapy with recurrent events in meta-analysis of multiple clinical trials.</p><p><strong>Methods: </strong>A nonparametric approach is proposed to estimate the rates of recurrent events for meta-analysis of trials. The method was used in meta-analysis of angiotensin-converting enzyme (ACE) inhibitor clinical trials to analyze the relative rates and the excess rates between ACE inhibitor and placebo treatment groups for endpoints of hospitalizations for CHF, hospitalizations for CHF or cardiac death, and hospitalizations for CHF or any death, respectively.</p><p><strong>Results: </strong>The estimates of those three endpoints were 69%, 74%, and 76% (P < 0.01). Compared with placebo, ACE inhibitor reduced 30 cases of hospitalizations for CHF per 1000 person-years, or 40 cardiac deaths or hospitalizations for CHF per 1000 person-years (P < 0.01).</p><p><strong>Conclusion: </strong>The method was a simple and efficient approach to conduct meta-analysis of clinical trials with recurrent events.</p>","PeriodicalId":24002,"journal":{"name":"Zhongguo yao li xue bao = Acta pharmacologica Sinica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1999-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhongguo yao li xue bao = Acta pharmacologica Sinica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To study the efficacy and safety of drug or therapy with recurrent events in meta-analysis of multiple clinical trials.

Methods: A nonparametric approach is proposed to estimate the rates of recurrent events for meta-analysis of trials. The method was used in meta-analysis of angiotensin-converting enzyme (ACE) inhibitor clinical trials to analyze the relative rates and the excess rates between ACE inhibitor and placebo treatment groups for endpoints of hospitalizations for CHF, hospitalizations for CHF or cardiac death, and hospitalizations for CHF or any death, respectively.

Results: The estimates of those three endpoints were 69%, 74%, and 76% (P < 0.01). Compared with placebo, ACE inhibitor reduced 30 cases of hospitalizations for CHF per 1000 person-years, or 40 cardiac deaths or hospitalizations for CHF per 1000 person-years (P < 0.01).

Conclusion: The method was a simple and efficient approach to conduct meta-analysis of clinical trials with recurrent events.

多项临床试验荟萃分析中的复发事件。
目的:通过多临床试验的荟萃分析,研究复发事件的药物或治疗的有效性和安全性。方法:提出了一种非参数方法来估计试验荟萃分析的复发事件率。该方法用于血管紧张素转换酶(ACE)抑制剂临床试验的荟萃分析,分别分析ACE抑制剂治疗组和安慰剂治疗组因CHF住院、因CHF或心源性死亡住院和因CHF或任何死亡住院的相对率和超额率。结果:三个终点的估计值分别为69%、74%和76% (P < 0.01)。与安慰剂相比,ACE抑制剂每1000人年减少30例瑞士法郎住院,或每1000人年减少40例心脏死亡或瑞士法郎住院(P < 0.01)。结论:该方法是一种简便、有效的临床试验复发事件荟萃分析方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信